Differences in T-cell responses between Mycobacterium tuberculosis and Mycobacterium africanum-infected patients

European Journal of Immunology

Volumn 44, Issue 5, 2014, Pages 1387-1398

  Tientcheu, Leopold D ^a,b   Sutherland, Jayne S ^a   de Jong, Bouke C ^c   Kampmann, Beate ^a   Jafali, James ^a   Adetifa, Ifedayo M ^a   Antonio, Martin ^a   Dockrell, Hazel M ^b   Ota, Martin O ^a,d  

^a Vaccinology Theme   (Gambia)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Cytokines; Mycobacterium africanum; Mycobacterium tuberculosis; T cells; Tuberculosis

Indexed keywords

BACTERIAL ANTIGEN; CULTURE FILTRATE PROTEIN 10; ETHAMBUTOL; GAMMA INTERFERON; INTERLEUKIN 2; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL IMMUNITY; BLOOD; CASE REPORT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; COMBINATION CHEMOTHERAPY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; FEMALE; HUMAN; LYMPHOCYTE COUNT; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM AFRICANUM; MYCOBACTERIUM AFRICANUM INFECTION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TUBERCULOSIS;

CYTOKINES; MYCOBACTERIUM AFRICANUM; MYCOBACTERIUM TUBERCULOSIS; T CELLS; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; SPECIES SPECIFICITY; TUBERCULOSIS;

EID: 84899534097     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201343956     Document Type: Article

References (40)

1. Global tuberculosis control: WHO (World Health Organization) Report 2012. http://www.who.int/tb/publications/global_report/archive/en/index.html.
2. de Jong, B. C., Antonio, M. and Gagneux, S., Mycobacterium africanum-review of an important cause of human tuberculosis in West Africa. PLoS Negl. Trop. Dis. 2010. 4: e744.
3. de Jong, B. C., Adetifa, I., Walther, B., Hill, P. C., Antonio, M., Ota, M. and Adegbola, R. A., Differences between tuberculosis cases infected with Mycobacterium africanum, West African type 2, relative to Euro-American Mycobacterium tuberculosis: an update. FEMS immunol. Med. Microbiol. 2010. 58: 102-105.
4. de Jong, B. C., Hill, P. C., Aiken, A., Awine, T., Antonio, M., Adetifa, I. M., Jackson-Sillah, D. J. et al., Progression to active tuberculosis, but not transmission, varies by Mycobacterium tuberculosis lineage in The Gambia. J. Infect. Dis. 2008. 198: 1037-1043.
5. Via, L. E., Weiner, D. M., Schimel, D., Lin, P. L., Dayao, E., Tankersley, S. L., Cai, Y. et al., Differential virulence and disease progression following Mycobacterium tuberculosis complex infection of the common marmoset (Callithrix jacchus). Infect. Immun. 2013. 81: 2909-2919.
6. Bold, T. D., Davis, D. C., Penberthy, K. K., Cox, L. M., Ernst, J. D. and de Jong, B. C., Impaired Fitness of Mycobacterium africanum despite secretion of ESAT-6. J. Infect. Dis. 2012. 205: 984-990
7. Grosset, J., Decroix, G. and Sors, C., Tuberculosis due to Mycobacterium africanum in African negroes in the Paris area]. Rev. Tuberc. Pneumol. (Paris) 1971. 35: 430-436.
8. Bentley, S. D., Comas, I., Bryant, J. M., Walker, D., Smith, N. H., Harris, S. R., Thurston, S. et al., The genome of Mycobacterium africanum West African 2 reveals a lineage-specific locus and genome erosion common to the M. tuberculosis complex. PLoS Negl. Trop. Dis. 2012. 6: e1552.
9. Gagneux, S., Host-pathogen coevolution in human tuberculosis. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 2012. 367:850-859.
10. de Jong, B. C., Hill, P. C., Brookes, R. H., Gagneux, S., Jeffries, D. J., Otu, J. K., Donkor, S. A. et al., Mycobacterium africanum elicits an attenuated T cell response to early secreted antigenic target, 6 kDa, in patients with tuberculosis and their household contacts. J. Infect. Dis. 2006. 193: 1279-1286.
11. Sutherland, J. S., de Jong, B. C., Jeffries, D. J., Adetifa, I. M. and Ota, M. O., Production of TNF-alpha, IL-12(p40) and IL-17 can discriminate between active TB disease and latent infection in a West African cohort. PLoS One 2010. 5: e12365.
12. Roederer, M., Nozzi, J. L. and Nason, M. C., SPICE: exploration and analysis of post-cytometric complex multivariate datasets. Cytometry A 2011. 79: 167-174.
13. Christensen, J. E., Andreasen, S. O., Christensen, J. P. and Thomsen, A. R., CD11b expression as a marker to distinguish between recently activated effector CD8(+) T cells and memory cells. Int. Immunol. 2001. 13: 593-600.
14. Wagner, C., Kotsougiani, D., Pioch, M., Prior, B., Wentzensen, A. and Hansch, G. M., T lymphocytes in acute bacterial infection: increased prevalence of CD11b(+) cells in the peripheral blood and recruitment to the infected site. Immunology 2008. 125: 503-509.
15. Nielsen, H. V., Christensen, J. P., Andersson, E. C., Marker, O. and Thomsen, A. R., Expression of type 3 complement receptor on activated CD8+ T cells facilitates homing to inflammatory sites. J. Immunol. 1994. 153: 2021-2028.
16. Kotsougiani, D., Pioch, M., Prior, B., Heppert, V., Hansch, G. M. and Wagner, C., Activation of T lymphocytes in response to persistent bacterial infection: induction of CD11b and of Toll-like receptors on T cells. Int. J. Inflam. 2010. 2010: 526740.
17. Wagner, C., Hansch, G. M., Stegmaier, S., Denefleh, B., Hug, F. and Schoels, M., The complement receptor 3, CR3 (CD11b/CD18), on T lymphocytes: activation-dependent up-regulation and regulatory function. Eur. J. Immunol. 2001. 31: 1173-1180.
18. Harari, A., Rozot, V., Enders, F. B., Perreau, M., Stalder, J. M., Nicod, L. P., Cavassini, M. et al., Dominant TNF-alpha+ Mycobacterium tuberculosis-specific CD4+ T cell responses discriminate between latent infection and active disease. Nat. Med. 2011. 17: 372-376.
19. Sutherland, J. S., Adetifa, I. M., Hill, P. C., Adegbola, R. A. and Ota, M. O., Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease. Eur. J. Immunol. 2009. 39: 723-729.
20. Day, C. L., Abrahams, D. A., Lerumo, L., Janse van Rensburg, E., Stone, L., O'Rie, T., Pienaar, B. et al., Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load. J. Immunol. 2011. 187: 2222-2232.
21. Young, J. M., Adetifa, I. M., Ota, M. O. and Sutherland, J. S., Expanded polyfunctional T cell response to mycobacterial antigens in TB disease and contraction post-treatment. PLoS One 2010. 5: e11237.
22. Caccamo, N., Guggino, G., Joosten, S. A., Gelsomino, G., Di Carlo, P., Titone, L., Galati, D. et al., Multifunctional CD4+ T cells correlate with active Mycobacterium tuberculosis infection. Eur. J. Immunol. 2010. 40: 2211-2220.
23. Streitz, M., Fuhrmann, S., Thomas, D., Cheek, E., Nomura, L., Maecker, H., Martus, P. et al., The phenotypic distribution and functional profile of tuberculin-specific CD4 T-cells characterizes different stages of TB infection. Cytometry B. Clin. Cytom. 2012. 82: 360-368.
24. Pollock, K. M., Whitworth, H. S., Montamat-Sicotte, D. J., Grass, L., Cooke, G. S., Kapembwa, M. S., Kon, O. M. et al., T-cell immunophenotyping distinguishes active from latent tuberculosis. J. Infect. Dis. 2013. 208: 952-968.
25. Rozot, V., Vigano, S., Mazza-Stalder, J., Idrizi, E., Day, C. L., Perreau, M. et al., Mycobacterium tuberculosis-specific CD8+ T cells are functionally and phenotypically different between latent infection and active disease. Eur. J. Immunol. 2013. 43: 1568-1577.
26. Keane, J., TNF-blocking agents and tuberculosis: new drugs illuminate an old topic. Rheumatology 2005. 44: 714-720.
27. Keane, J., Gershon, S., Wise, R. P., Mirabile-Levens, E., Kasznica, J., Schwieterman, W. D., Siegel, J. N. and Braun, M. M., Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N. Engl. J. Med. 2001. 345: 1098-1104.
28. Bekker, L. G., Moreira, A. L., Bergtold, A., Freeman, S., Ryffel, B. and Kaplan, G., Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose dependent. Infect. Immun. 2000. 68: 6954-6961.
29. Skerry, C., Harper, J., Klunk, M., Bishai, W. R. and Jain, S. K., Adjunctive TNF inhibition with standard treatment enhances bacterial clearance in a murine model of necrotic TB granulomas. PLoS One 2012. 7: e39680.
30. Day, C. L., Mkhwanazi, N., Reddy, S., Mncube, Z., van der Stok, M., Klenerman, P. and Walker, B. D., Detection of polyfunctional Mycobacterium tuberculosis-specific T cells and association with viral load in HIV-1-infected persons. J. Infect. Dis. 2008. 197: 990-999.
31. Ernst, J. D., The immunological life cycle of tuberculosis. Nat. Rev. Immunol. 2012. 12: 581-591.
32. Singh, A., Dey, A. B., Mohan, A., Sharma, P. K. and Mitra, D. K., Foxp3(+) regulatory T cells among tuberculosis patients: impact on prognosis and restoration of antigen specific IFN-gamma producing T cells. PLoS One 2012. 7: e44728.
33. Lewinsohn, D. M., Zhu, L., Madison, V. J., Dillon, D. C., Fling, S. P., Reed, S. G., Grabstein, K. H. and Alderson, M. R., Classically restricted human CD8+ T lymphocytes derived from Mycobacterium tuberculosis-infected cells: definition of antigenic specificity. J. Immunol. 2001. 166: 439-446.
34. Lewinsohn, D. A., Heinzel, A. S., Gardner, J. M., Zhu, L., Alderson, M. R. and Lewinsohn, D. M., Mycobacterium tuberculosis-specific CD8+ T cells preferentially recognize heavily infected cells. Am. J. Respir. Crit. Care Med. 2003. 168: 1346-1352.
35. Torok, M. E., Reuter, S., Bryant, J., Koser, C. U., Stinchcombe, S. V., Nazareth, B., Ellington, M. J. et al., Rapid whole-genome sequencing for investigation of a suspected tuberculosis outbreak. J. Clin. Microbiol. 2013. 51: 611-614.
36. Koser, C. U., Bryant, J. M., Becq, J., Torok, M. E., Ellington, M. J., Marti-Renom, M. A., Carmichael, A. J. et al., Whole-genome sequencing for rapid susceptibility testing of M. tuberculosis. N. Engl. J. Med. 2013. 369: 290-292.
37. de Jong, B. C., Hill, P. C., Aiken, A., Jeffries, D. J., Onipede, A., Small, P. M., Adegbola, R. A. and Corrah, T. P., Clinical presentation and outcome of tuberculosis patients infected by M. africanum versus M. tuberculosis. Int. J. Tuberc. Lung. Dis. 2007. 11: 450-456.
38. Treatment of Tuberculosis: guidelines for national programmes 4th edition. WHO (World Health Organisation) 2010. http://www.who.int/entity/tb/publications/tb_treatmentguidelines/en/index.html.
39. Aldous, W. K., Pounder, J. I., Cloud, J. L. and Woods, G. L., Comparison of six methods of extracting Mycobacterium tuberculosis DNA from processed sputum for testing by quantitative real-time PCR. J. Clin. Microbiol. 2005. 43: 2471-2473.
40. de Jong, B. C., Antonio, M., Awine, T., Ogungbemi, K., de Jong, Y. P., Gagneux, S., DeRiemer, K. et al., Use of spoligotyping and large sequence polymorphisms to study the population structure of the Mycobacterium tuberculosis complex in a cohort study of consecutive smear-positive tuberculosis cases in The Gambia. J. Clin. Microbiol. 2009. 47: 994-1001.